Table of Contents Table of Contents
Previous Page  177 / 1631 Next Page
Information
Show Menu
Previous Page 177 / 1631 Next Page
Page Background

Clinical consequences

Prevention of CRC in HL survivors

Population screening?

Surveillance programs?

Courtesy: L. Rigter